Achaogen
  • Company Overview Our Focus Our Culture Management Team Board of Directors
  • Product
  • Pipeline Overview C-Scape Monoclonal Antibody Program Novel Aminoglycosides Our Approach to R&D Scientific Publications
  • Investor Overview Press Releases Events & Presentations Corporate Governance Financials & Filings Stock Information Contact Us
  • Overview Values Benefits Positions Available
  • Contact Us
Achaogen
  • About Us/
    • Company Overview
    • Our Focus
    • Our Culture
    • Management Team
    • Board of Directors
  • Product/
  • Pipeline/
    • Pipeline Overview
    • C-Scape
    • Monoclonal Antibody Program
    • Novel Aminoglycosides
    • Our Approach to R&D
    • Scientific Publications
  • Investors/
    • Investor Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financials & Filings
    • Stock Information
    • Contact Us
  • Careers/
    • Overview
    • Values
    • Benefits
    • Positions Available
  • Contact Us/
  • /
Proteus v3 (low res).jpg
Achaogen

Media

Achaogen
  • About Us/
    • Company Overview
    • Our Focus
    • Our Culture
    • Management Team
    • Board of Directors
  • Product/
  • Pipeline/
    • Pipeline Overview
    • C-Scape
    • Monoclonal Antibody Program
    • Novel Aminoglycosides
    • Our Approach to R&D
    • Scientific Publications
  • Investors/
    • Investor Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financials & Filings
    • Stock Information
    • Contact Us
  • Careers/
    • Overview
    • Values
    • Benefits
    • Positions Available
  • Contact Us/
  • /
December 03, 2010

Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City

December 03, 2010/ Ian C. Olson

David Landman, Paul Kelly, Martin Bäcker, Elizabeth Babu, Neha Shah, Simona Bratu and John Quale
J. Antimicrob. Chemother. (2010)  doi: 10.1093/jac/dkq459

Access this publication @ jac.oxfordjournals.org

 

December 03, 2010/ Ian C. Olson/
Scientific Publications
2010, Plazomicin, Plazomicin 2010

Ian C. Olson

  • In vivo efficacy of the ...
  • Activity of aminoglycosides, ...

© Achaogen, Inc. 2004-present. All rights reserved.     Privacy Policy | Terms of Use